Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mason W Freeman

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient miceKang K Yang, Brigitte G Dorner, Ulrike Merkel, et al.
Diabetes, Obesity & Metabolism|September 30, 2022
A 96-week, double-blind, randomized controlled trial comparing bexagliflozin to glimepiride as an adjunct to metformin for the treatment of type 2 diabetes in adultsYuan-Di Halvorsen, John Paul Lock, Juan P Frias, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2007
Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defectsRobert S Kiss, Nihan Kavaslar, Kei-ichiro Okuhira, et al.
The Journal of Biological Chemistry|September 30, 2005
Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol effluxKei-ichiro Okuhira, Michael L Fitzgerald, David A Sarracino, et al.
Journal of Clinical and Translational Science|August 9, 2021
An overview of the process, progress, and outcomes of a National Center for Accelerated Innovation: The Boston Biomedical Innovation Center ExperienceElliott M Antman, Mason W Freeman, David E Golan, et al.
The Journal of Experimental Medicine|June 11, 2003
CD36 mediates the innate host response to beta-amyloidJoseph B El Khoury, Kathryn J Moore, Terry K Means, et al.
The Journal of Clinical Investigation|August 3, 2005
Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic miceKathryn J Moore, Vidya V Kunjathoor, Stephanie L Koehn, et al.
Journal of Lipid Research|December 3, 2013
Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier functionJorge F Haller, Paul Cavallaro, Nicholas J Hernandez, et al.
ESC Heart Failure|May 17, 2018
Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DNBertram Pitt, George L Bakris, Matthew R Weir, et al.
The Journal of Biological Chemistry|October 30, 2008
ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic estersYing Zuo, Debbie Z Zhuang, Rong Han, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient miceKang K Yang, Brigitte G Dorner, Ulrike Merkel, et al.
Diabetes, Obesity & Metabolism|September 30, 2022
A 96-week, double-blind, randomized controlled trial comparing bexagliflozin to glimepiride as an adjunct to metformin for the treatment of type 2 diabetes in adultsYuan-Di Halvorsen, John Paul Lock, Juan P Frias, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2007
Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defectsRobert S Kiss, Nihan Kavaslar, Kei-ichiro Okuhira, et al.
The Journal of Biological Chemistry|September 30, 2005
Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol effluxKei-ichiro Okuhira, Michael L Fitzgerald, David A Sarracino, et al.
Journal of Clinical and Translational Science|August 9, 2021
An overview of the process, progress, and outcomes of a National Center for Accelerated Innovation: The Boston Biomedical Innovation Center ExperienceElliott M Antman, Mason W Freeman, David E Golan, et al.
The Journal of Experimental Medicine|June 11, 2003
CD36 mediates the innate host response to beta-amyloidJoseph B El Khoury, Kathryn J Moore, Terry K Means, et al.
The Journal of Clinical Investigation|August 3, 2005
Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic miceKathryn J Moore, Vidya V Kunjathoor, Stephanie L Koehn, et al.
Journal of Lipid Research|December 3, 2013
Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier functionJorge F Haller, Paul Cavallaro, Nicholas J Hernandez, et al.
ESC Heart Failure|May 17, 2018
Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DNBertram Pitt, George L Bakris, Matthew R Weir, et al.
The Journal of Biological Chemistry|October 30, 2008
ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic estersYing Zuo, Debbie Z Zhuang, Rong Han, et al.
Pageof 7